Graeme Clark Collection

Permanent URI for this collection

Search Results

Now showing 1 - 2 of 2
  • Item
    Thumbnail Image
    The University of Melbourne/Nucleus cochlear prosthesis
    Clark, Graeme M. ; Blamey, P. J. ; Brown, A. M. ; Busby, P. A. ; Dowell, R. C. ; Franz, B. K-H. ; Millar, J. B. ; Pyman, B. C. ; Shepherd, R. K. ; Tong, Y. C. ; Webb, R. L. ; Brimacombe, J. A. ; Hirshorn, M. S. ; Kuzma, J. ; Mecklenburg, D. J. ; Money, D. K. ; Patrick, J. F. ; Seligman, P. M. ( 1988)
    This is a review of research to develop the University of Melbourne/Nucleus cochlear prosthesis for patients with a profound-total hearing loss. A more complete review can be obtained in Clark et al. A prototype receiver-stimulator and multiple-electrode array developed at the University of Melbourne was first implanted in a postlingually deaf adult patient with a profound-total hearing loss on 1 August 1978. A speech processing strategy which could help this patient understand running speech, especially when combined with lipreading was developed in 1978 following initial psychophysical studies. A prototype wearable speech processor was fabricated in 1979, that could provide significant help for the first two patients in understanding running speech when used in combination with lipreading compared with lipreading alone, and it also enabled them to understand some running speech when using electrical stimulation alone. An implantable receiver-stimulator and wearable speech processor embodying the principles of the prototype devices were then produced for clinical trial by the Australian biomedical firm, Nucleus Ltd, and its subsidiaries, Cochlear Pty Ltd and Cochlear Corporation. This cochlear implant was initially clinically trialled on six patients at The Royal Victorian Eye & Ear Hospital in 1982, and shown to give similar results to those obtained with the prototype device. In view of these findings a clinical trial was carried out for a Premarket Approval Application to the US Food and Drug Administration (FDA), and extended to a number of centres in the US, Canada, and West Germany. This clinical trial confirmed that patients could understand running speech when electrical stimulation was combined with lipreading, and that some patients could also understand running speech when using electrical stimulation alone. Today, more than 600 patients world-wide are using cochlear implants developed from the research described in this paper.
  • Item
    Thumbnail Image
    Signal processing in quiet and noise
    Dowell, R. C. ; Patrick, J. F. ; Blamey, P. J. ; Seligman, P. M. ; Money, D. K. ; Clark, Graeme M. ( 1987)
    It has been shown that many profoundly deaf patients using multichannel cochlear implants are able to understand significant amounts of conversational speech using the prosthesis without the aid of lipreading. These results are usually obtained under ideal acoustic conditions but, unfortunately, the environments in which the prostheses are most often used are rarely perfect. Some form of competing signal is always present in the urban setting, from other conversations, radio and television, appliances, traffic noise and so on. As might be expected, implant users in general find background noise to be the largest detrimental factor in their understanding of speech, both with and without the aid of lipreading. Recently, some assessment of implant patient performance with competing noise has been attempted using a four-alternative forced-choice spondee test (1) at Iowa University. Similar testing has been carried out at the University of Melbourne with a group of patients using the Nucleus multichannel cochlear prosthesis. This study formed part of an assessment of a two formant (F0/FI/F2) speech coding strategy (2). Results suggested that the new scheme provided improved speech recognition both in quiet and with competing noise. This paper reports on some more detailed investigations into the effects of background noise on speech recognition for multichannel cochlear implant users.